Alvotech (ALVO) Exchange Rate Effect (2021 - 2026)
Alvotech (ALVO) posted Exchange Rate Effect of $1.3 million for Q1 2026, up 107.75% on a QoQ basis from -$16.7 million in Q4 2025, and down 83.67% year-over-year from $7.9 million in Q1 2025.
Alvotech (ALVO) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Alvotech's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Exchange Rate Effect fell 83.67% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 116.17% YoY) and the FY2025 annual result came in at $4.5 million, up 440.71% from the prior year.
- Exchange Rate Effect was $1.3 million for Q1 2026 at Alvotech, up from -$16.7 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $17.8 million in Q3 2025 and bottomed at -$16.7 million in Q4 2025.
- A 5-year average of $466170.9 and a median of $825564.0 in 2024 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 2056.47% in 2025, while the deepest fall reached 1162.46% in 2025.
- Alvotech's Exchange Rate Effect stood at -$113000.0 in 2022, then sank by 71.68% to -$194000.0 in 2023, then slumped by 582.47% to -$1.3 million in 2024, then sank by 1162.46% to -$16.7 million in 2025, then surged by 107.75% to $1.3 million in 2026.
- Business Quant data shows ALVO's Exchange Rate Effect at $1.3 million in Q1 2026, -$16.7 million in Q4 2025, and $17.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -16.72 Mn |
| Dec 31, 2025 | -16.72 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | -4.51 Mn |
| Jun 30, 2025 | -4.51 Mn |
| Mar 31, 2025 | 7.93 Mn |
| Mar 31, 2025 | 7.93 Mn |
| Dec 31, 2024 | -1.32 Mn |
| Dec 31, 2024 | -1.32 Mn |
| Sep 30, 2024 | 825,564.00 |
| Sep 30, 2024 | 825,564.00 |
| Jun 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | -6.53 Mn |
| Mar 31, 2024 | -6.53 Mn |
| Dec 31, 2023 | -194,000.00 |
| Dec 31, 2023 | -194,000.00 |